Pablo Engel

12PUBLICATIONS
87CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 20, 2025
CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors.

Javier Fernández-Calles, Daniela Kužílková, Fanny Hedin

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|May 30, 2025
Human LY9 governs CD4+ T cell IFN-γ immunity to Mycobacterium tuberculosis.

Masato Ogishi, Julia Puchan, Rui Yang

|May 14, 2022
CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma.

Giovanna Roncador, Joan Puñet-Ortiz, Lorena Maestre

|Apr 12, 2022
SIRPα - CD47 axis regulates dendritic cell-T cell interactions and TCR activation during T cell priming in spleen.

Anu Autio, Huan Wang, Francisco Velázquez

|Jan 18, 2021
Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion.

Guillem Angulo, Jelena Zeleznjak, Pablo Martínez-Vicente

Pageof 2

Frequent Collaborators

2 joint publications

Ana Angulo

2 joint publications

Pablo Martínez-Vicente

2 joint publications

Carlos Fernández de Larrea

2 joint publications

Luis Gerardo Rodríguez-Lobato